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ASSESSING TREATMENT RESPONSE USING DAILY MEASURES OF 
PHYSICAL ACTIVITY, FEAR, AND AVOIDANCE IN YOUTH WITH 
CHRONIC PAIN 
 
FARAH MAHMUD 
ABSTRACT 
 This study assessed physical activity levels and subjective measures of fear and 
avoidance in youth with chronic pain, and examined the effects of graded exposure-based 
treatment on these relations. Children and adolescents with chronic pain participated in a 
series of individualized treatment sessions involving a parent, physical therapist and 
psychologist. The early sessions consisted of psychoeducation and the later sessions 
consisted of exposure activities in which patients were gradually exposed to activities 
they had been avoiding due to pain or fear. While in treatment each participant wore an 
actigraph, a wrist watch used to monitor physical activity, and completed daily diaries in 
which they reported fear and avoidance ratings. Actigraph data were used to calculate 
mean and peak activity per minute. Data were examined across treatment phases. 
Participants in this study were 10 children and adolescents (ranging in age from 8-17) 
with chronic pain. The study was divided into Baseline, Education and Exposure periods. 
Treatment ranged from 9 to 15 sessions. Across time, mean and peak activity remained at 
baseline levels, while avoidance reports decreased over the course of treatment. 
Curvilinear regression models estimated moderate relationships between physical activity 
levels and reports of avoidance and pain, with more activity observed at lower and higher 
(rather than moderate) levels of self-reported avoidance and pain. Linear mixed models 
	  	   vii 
did not demonstrate any interactions between physical activity and avoidance, and 
physical activity and fear, by treatment phase. These findings suggest that the relations 
between physical activity, pain perception, fear, and activity avoidance in youth with 
chronic pain is complex and warrants further inquiry.  
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INTRODUCTION 
 
 It is widely known that chronic pain is common in the adult population, but it is 
also highly prevalent among children and adolescents (Coffelt et al 2013). The number of 
children reporting recurrent and chronic pain has grown over the years. Unlike acute pain 
which indicates possible injury or disease, chronic pain is typically defined as pain lasting 
for more than three months, even after the injured tissues have healed. Prevalence rates 
range from 11 to 38%, with higher rates in older girls (King et al 2011). While the 
potential biological, psychological and sociocultural causes and contributors have been 
hypothesized, it remains unclear exactly how and why some children develop chronic 
pain, while others do not (Liossi & Howard 2016).  
 
Chronic pain in youth. 
 Coffelt et al (2013) conducted a retrospective cohort study to better understand 
the inpatient characteristics of children with chronic pain. The study included 3752 
chronic pain patients from 2004 to 2010. Admissions increased more than 8-fold during 
this time period (Figure 1). They also found that patients were most commonly white 
females, with an average age of 13.5 years. Comorbid diagnoses were highly common, 
particularly gastrointestinal and psychiatric diagnoses. Anxiety and depression were most 
common among patients with a psychiatric diagnosis.   
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Figure 1. Number of children admitted to an inpatient setting with chronic pain from 2004 to 
2010 (Coffelt et al 2013). 
 
 Common pain types in the pediatric population include neuropathic pain, complex 
regional pain syndrome (CRPS), headache, abdominal pain and musculoskeletal pain. 
Neuropathic pain is defined as being caused by lesion of the somatosensory nervous 
system (Howard et al 2014). CRPS is caused by damage to the peripheral and central 
nervous system, and it typically affects a limb following an injury (Stanton-Hicks 2010). 
Chronic musculoskeletal pain can be localized or generalized and have highly variable 
causes (Clinch & Eccleston 2009). Primary headache disorders, most commonly 
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migraines, are common in children but have better treatment outcomes compared to 
adults with chronic headaches (Rajapakse et al 2014). Chronic abdominal pain is 
characterized by a minimum of three pain episodes interfering with function over the 
course of at least three months (Di Lorenzo et al 2005). Presentation and treatment 
response of all these pain conditions have shown to be different in youth from adults 
(Rajapakse et al 2014). Thus, study of various pain types at all developmental stages is 
essential.  
 
Influence of fear and avoidance. 
Persistent pain often leads to fear and avoidance of activities that may, in turn, trigger or 
worsen the pain. By repeatedly avoiding activities as a result of pain anticipation and 
body protection, the condition may worsen from disuse; thus the avoidance behavior 
becomes maladaptive (Simons et al 2014). This process is depicted in the Fear Avoidance 
Model of Chronic Pain which has been well established in adults with chronic pain 
(Figure 1) (Vlaeyen & Linton 2012, Vlaeyen et al 2016, Vlaeyen & Linton 2000).  
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Figure 2. The Fear-Avoidance Model. When stimuli or activities associated with pain are 
seen as threatening, this is known as pain catastrophizing, and it leads to development of fears 
of pain, re-injury and physical activity. These pain-related fears lead to hypervigilance and 
avoidance behaviors that maintain or exacerbate pain, thus instigating a continuous cycle of 
pain, catastrophizing, fear and avoidance, which ultimately furthers pain-related disability 
and prevents recovery (Vlaeyen et al 2016). 
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 Simons and Kaczynski (2012) assessed the application of the fear-avoidance 
model in pediatric populations. They examined whether pain, catastrophizing, fear of 
pain and avoidance from the model could predict functional disability and depressive 
symptoms in a sample of 350 children (8-12 years) and adolescents (13-17 years) with 
various forms of chronic pain. The researchers found that the model was successful in 
predicting functional disability. The model did not however predict depression as 
accurately. They also found developmental differences as pain-related fear affected 
avoidance behavior more in adolescents than younger children, and avoidance behavior 
was significantly more common in adolescents. Additionally, functional disability was 
significantly higher in adolescents at the one-month follow up to the clinic visit. This 
study showed that the fear avoidance model can be applied to youth, but that there are 
important differences in the fear-avoidance pathway between younger and older patients.  
 Due to the cycle of pain, fear and avoidance, youth with chronic pain frequently 
limit their daily activities (Konijnenberg et al 2005, Palermo et al 2004). Roth-Isigkeit et 
al (2005) conducted a study on 749 children and adolescents in order to assess activity 
limitations among those with chronic pain. More than 66% of those with pain reported 
restrictions in daily living attributable to pain. These restrictions included school absence, 
inability to engage with peers and inability to pursue hobbies (Figure 3). They also found 
that limitations in daily living increased with age, potentially due to older children having 
more agency to choose to avoid activities than younger children (Simons & Kaczynski 
2012). 
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Figure 3. Daily limitations due to pain. The y-axis indicates percent of youth with chronic pain 
(Roth-Isigkeit et al 2005). 
 
Physical activity and chronic pain.  
 Fear-avoidance beliefs about physical activity have been associated with 
increased pain perception and functional disability. These include beliefs like “Physical 
activity makes my pain worse” or “I cannot do physical activities that make my pain 
worse”, which associate pain with physical activity (Wilson et al 2011). Thus targeting 
fear-avoidance beliefs specifically pertaining to physical activity during treatment may be 
effective in improving functional disability and limitations in adolescents with chronic 
pain.  
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 Assessment of physical activity. Given the importance of physical activity on 
health, striving for accurate and objective measurement of this behavior is important. 
Actigraphy is commonly used to measure physical activity levels and supplement self-
reports from patients and parents. The objectivity of actigraphy makes it particularly 
useful in the study of the chronic pain youth population. Adolescent and parent 
perception of physical functioning may not accurately reflect physical activity levels 
during various activities; self-report measures can be prone to response shift and reporter 
bias, among several other sources of bias. Unlike laboratory-based objective measures of 
physical activity, such as timed walks, peak oxygen consumption during exercise, grip 
strength and extension force, actigraphy provides the unique ability to unobtrusively 
measure activity levels for extended periods of time during daily life routines (Long et al 
2008). This allows researchers to gain a better understanding of physical functioning in 
this population. 
 
 Decreased physical activity. Decreased physical activity is common among 
chronic pain patients. Konijnenberg et al (2005) evaluated youth from an outpatient clinic 
and found that the most prevalent reported impairment among children with chronic pain 
was in sports/physical activity. A total of 72% of the children reduced, changed or 
withdrew from their sports activities and gym classes due to their pain (Konijnenberg et 
al 2005). Other studies that used actigraphy to objectively examine physical activity also 
observed lower mean and peak activity levels in adolescents with chronic pain compared 
to healthy adolescents, consistent with subjective measurement findings (Long et al 2008, 
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Wilson & Palermo 2012). These findings raise concerns since adequate physical activity 
is crucial for maintaining physical and mental health in all individuals, particularly 
chronic pain patients. Physical activity is known to improve sleep, which is often 
disrupted in children with persistent pain, as previously mentioned. Mood is also 
enhanced by physical activity. Research has shown that inactivity is associated with 
depressive and anxiety symptoms in fibromyalgia patients (Gauffin et al 2013, Kashikar-
Zuck et al 2010, Sener et al 2016). Overall, physical activity has significant benefits in 
pain management due to its influence on mood, anxiety and sleep, all of which are 
commonly impaired in patients with comorbid chronic pain.  
 
 Pain sensitivity and physical activity. Rabbitts et al (2014) demonstrated the more 
immediate effects of physical activity on pain sensitivity in adolescents with chronic 
pain. They examined physical activity in a sample of 119 adolescents, about half of 
which suffered from chronic pain while the other half were healthy. Subjects wore an 
actigraphic device (wrist Actiwatch) for a period of ten days, during which they also 
completed daily diaries reporting their pain intensity, sleep quality, mood and medication 
use. Pain intensity was rated each day on an 11-point numerical rating scale in which a 0 
rating meant no pain and 10 meant worst pain. On average, the chronic pain group 
reported moderate daily pain intensity and the healthy control group reported low pain 
intensity. Additionally, they found that mean and peak physical activity levels were 14% 
and 20% lower, respectively, for adolescents with chronic pain compared to healthy 
adolescents over the ten-day period. More interestingly, they observed that higher mean 
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activity levels were associated with lower pain intensity ratings at the end of the day, only 
in the chronic pain group. Peak activity levels did not have significant associations with 
end of day pain. Furthermore, they concluded that physical mean activity is predictive of 
end of day pain in adolescents with chronic pain. Medication use and previous night sleep 
quality also emerged as significant predictors of end of day pain in the chronic pain 
group. A major limitation of this study, however, was that they did not consider other 
factors, such as pain-related fear and parent behaviors, which could have influenced 
activity levels in the chronic pain group (Rabbitts et al 2014). Nevertheless, their findings 
underscore the importance for chronic pain patients to maintain or increase physical 
activity regardless of pain intensity in order to promote recovery, especially given the 
apparent immediate effects of activity changes on pain sensitivity.  
 This study also revealed the bidirectional nature of the pain and activity 
relationship. Rabbitts et al (2014) analyzed additional linear models in which pain was 
measured as a predictor of mean and peak physical activity on the following day. They 
found that higher pain ratings were associated with lower next day peak activity in all 
adolescents. The authors suggest that high pain levels on a given day may physically 
prevent children from achieving high levels of physical activity. Therefore, the intimate 
relationship that physical activity has with pain, as well as its significant physiological 
and psychological benefits, make physical activity an essential part of pain management 
for youth with chronic pain.  
 Targeting physical activity in treatment. Randomized controlled trials have shown 
the efficacy of exercise in reducing pain in chronic pain patients (Ambrose & Golightly 
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2015). There are several recommended activity types including: aerobic exercise, strength 
training, flexibility training and movement therapies such as yoga and Tai Chi. In 
addition to improving pain and physical fitness, they also showed evidence for improving 
anxiety, depression and quality of life. Multimodal exercise programs involving different 
activities have been highly effective in improving pain (Ambrose & Golightly 2015, 
Stavropoulos-Kalinoglou et al 2013). According to clinical studies, a combination of 
physical activity and other therapy strategies is effective in improving pain and 
functioning in adults with chronic pain (Koele et al 2014, Volker et al 2016).  
 This multidisciplinary approach should be taken in pediatric pain treatment as 
well. Since chronic pain in youth involves several different biological, psychological and 
sociocultural factors, a unimodal treatment plan will not be as effective in reducing pain 
(Liossi & Howard 2016). A more appropriate approach would be a combination of 
physical therapy and psychotherapy. Hechler et al (2010) did just that in their inpatient 
pediatric treatment program. Treatment lasted three weeks and required the involvement 
of the patient’s family, clinical psychologists, psychiatrists, physiotherapists, 
occupational therapists, nurses and social workers. Psychotherapy sessions, some of 
which were with the family, patient group or individualized, involved operant and 
cognitive behavioral principles. Parents also received psychoeducation about the 
biopsychosocial model of chronic pain and were trained to encourage their child to take 
part in daily activities. Additionally, practicing new-learned strategies at home was an 
important part of treatment. After collecting data from 33 children (7-10 years) and 167 
adolescents (11-18 years) who went through the program, they found that pain-related 
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disability significantly decreased following treatment in both children and adolescents, 
and even more so in boys (Figure 3). School absence also significantly decreased in 
children and adolescents. Additionally patient use of analgesics significantly declined at  
the 3-month follow-up (Hechler et al 2010). Overall, this multimodal treatment program 
was highly effective in improving pain and functional disability in children and 
adolescents. A recent meta-analysis of intensive pain rehabilitation programs underscores 
that multimodal treatment for chronic pain is very effective for improving functioning 
and pain (Hechler et al 2015). 
 
Figure 4. Pain intensity at admission, 3-month follow-up and 12-month follow-up. Y-axis 
indicates NRS: Numeric rating scale (0-10). (Hechler et al 2010) 
 
 At present, the majority of psychological treatments for pediatric chronic pain 
target strategies to cope with pain and address depressive and anxiety symptomology. 
However, Simons et al (2012a) demonstrated the importance of also addressing pain-
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related fears through cognitive behavioral techniques as part of pain treatment. In their 
study, they evaluated fear of pain, disability and depression in youth with neuropathic 
pain in the context of an intensive pain rehabilitation program. They found that reduced 
pain-related fear was significantly associated with decreased disability and depressive 
symptoms. Moreover, higher levels of pain-related fear at admission was associated with 
less improvement, suggesting that treatments specifically target pain-related fears are in 
need. 
 Pain-related fear is reinforced and maintained by persistent avoidance behaviors 
which provide immediate relief of escaping expected threat (Vlaeyen et al 2016). 
However, the goal to avoid pain can be challenged by more highly valued life goals. If 
these kinds of high-value goals are focused on in treatment, avoidance behaviors can be 
inhibited in daily life. Additionally prioritizing life goals can be promoted by positive 
affect (Hanssen et al 2013).  
 Graded exposure treatment (GET) is a cognitive-behavioral-based therapy which 
involves gradually exposing patients to valued activities they had been avoiding due to 
fear of pain or re-injury. This kind of treatment has been shown to effectively target fear 
of pain and disability in adults with chronic pain (Bailey et al 2010, de Jong et al 2005a, 
de Jong et al 2005b, Vlaeyen et al 2002). Only a few studies have used GET in youth 
with chronic pain but they have shown promising results in improving pain-related fear 
and perceived pain (Simons 2016, Wicksell et al 2009). This thesis aims to examine 
changes in physical activity in relation to GET treatment and how changes in physical 
activity are related to daily reports of fear, avoidance, and pain levels. It is hypothesized 
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that physical activity will increase throughout treatment, and physical activity will be 
inversely related to fear, pain and avoidance. These daily self-reports are hypothesized to 
be correlated with each other and decrease with GET treatment.  
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METHODS 	  
Participants  
Patients were recruited from the Chronic Pain Clinic and Pediatric Headache Program 
within the Pain Treatment Service at Boston Children’s Hospital. Eligible patients were 
between the ages of 8 to 17, and had headache, musculoskeletal pain, neuropathic limb 
pain or back pain for at least three months. They also scored greater than 40 on the Fear 
of Pain Questionnaire (Simons et al 2011) and greater than 12 on the Functional 
Disability Inventory. Patients with significant cognitive impairment, psychopathology, 
acute trauma or systemic disease were excluded. Although parents of the patients 
participated in the study, the present study focuses on the data for the children only. This 
project was approved and maintained by the Boston Children’s Hospital Institutional 
Review Board (IRB-P 00007276).  
 
Procedure  
Prior to starting the GET Living treatment, participants completed a baseline period 
ranging from 7-21 days, during which they completed online daily diaries. After baseline, 
patients began treatment and completed daily diaries until the final session. There were 
also 3-month and 6- month follow-ups during which participants completed daily diaries 
for seven days (Figure 3).  
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Figure 5. Study timeline. Treatment took place over 6-10 weeks. Follow-ups occurred 3 and 6 
months following end of treatment.  
 
The treatment period consisted of a series of individualized sessions involving a 
parent, physical therapist and cognitive-behavioral pain therapist. Sessions were 45 
minutes long and administered twice a week for up to ten weeks. Treatment was divided 
into five phases. Phase I aimed to build rapport, educate the participant and family about 
the fear-avoidance model of pain and present the treatment rationale. Phase II aimed to 
improve motivation by setting values-based treatment goals. During Phase III, the 
participant created a pain-related fear hierarchy in which they picked out daily life 
activities important to them and ordered them by level of difficulty. They also created the 
Exposure Action Plan (EAP) in which the patient thinks of ways to cope during a 
challenging activity. They are encouraged to use active coping strategies, such as 
breathing or stretching, rather than stopping the activity completely. Phase IV consisted 
of exposures of activities from the pain-related fear hierarchy created by the participant. 
Each time they did an activity during GET Living sessions, the participant was asked to 
use the WILD (Willingness, Importance, Likelihood of success, Difficulty) scale before 
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and after the activity in order to assess their own progress. This scale asks about 
willingness to do an activity, how important the activity is in their life, how likely they 
think they will be successful with the activity and how difficult they think the activity 
will be. Once patients built confidence with exposure activities in treatment sessions, they 
completed exposures at home on a daily basis. Phase V aimed to review the patient’s 
progress and discuss how to prevent future relapse.  
 
Measures 
Daily Diaries 
Children completed online surveys during the baseline period prior to treatment, and all 
throughout treatment. These daily diaries consisted of selected items from the Fear of 
Pain Questionnaire (Simons et al 2011), the Pain Catastrophizing Scale (Crombez et al 
2003), the Chronic Pain Acceptance Questionnaire-Activity Engagement subscale 
(McCracken et al 2010) and a current numerical pain rating (von Baeyer et al 2009). The 
daily diary consisted of a total of 12 items, three of which were used to assess 
catastrophizing, three for acceptance, three for fear (“Feelings of pain were scary for 
me”; “I worried about my pain”; “When I had pain, I wondered whether something 
serious would happen”) and two for avoidance (“I put things off because of my pain”; “I 
avoided making plans because of my pain”); the scale ranged from 0 (strongly disagree) 
to 10 (strongly agree). Pain was assessed by one item: “How much pain you are feeling 
right now?”, in which the scale ranged from 0 (no pain) to 10 (worst pain has ever been). 
This thesis only focused on fear, pain and avoidance measures. 
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Actigraphy 
During the baseline and treatment periods, participants wore Actigraphs on the non-
dominant wrist. These electronic devices continuously monitored physical activity. 
ActiLife software was used to extract data from the Actigraphs, and calculate five types 
of activity scores from the data. Mean activity level was calculated as the mean number 
of activity counts per one-minute epoch for each day. Peak activity level was calculated 
as the highest number of activity counts achieved in a single one-minute epoch for each 
day. Moderate activity was measured as the number of one-minute epochs per day of 
activity counts greater than or equal to 1400 (as per Riddoch et al., 2004). Light activity 
was measured as the number of one-minute epochs per day of activity counts between 40 
and 1400. Sedentary activity was measured as the number of one-minute epochs per day 
of activity counts less than or equal to 40. 
 
Analyses 
 Descriptive analyses were conducted on each of the daily measures at each phase 
and summarized using daily means, variances and frequency distributions. Paired t-tests 
were used for preliminary analyses to examine differences in measures between phases. 
Linear growth models for mean and peak physical activity were estimated for each 
participant in order to visually and statistically assess changes in physical activity over 
time.  
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 Pearson correlation coefficients were calculated for preliminary analyses of 
relationships between each of the daily diary measures and physical activity measures. 
Regression models were estimated for measures showing moderate preliminary 
correlations in order to find the best fit models. Finally linear mixed models were used to 
account for phases and examine the effects of treatment on the above relationships. The 
SPSS Statistics software package was used to analyze all data.  
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 RESULTS 
  
Descriptive Statistics 
 A total of 14 participants were recruited, ten of which were included in the 
present study based on treatment completion and sufficient data collection. Participants 
were 90% female with ages ranging from 10 to 17 years (Table 1). Table 2 presents 
summary statistics of the sessions completed, number of baseline and treatment days, and 
percentage of completed data. Number of sessions ranged from 9 to 15, with an average 
of about 61 treatment days. Since days with missing daily diary or actigraphy data were 
excluded from the analysis, 30% of the sample had less than 60% complete data for 
analysis. 
 
 
Table 1. Patient Demographics 
Patient Gender Age Pain Diagnosis 
T19 Female 13 Shoulder pain 
T20 Female 10 Headache, Leg pain, Abdominal pain 
T21 Female 11 Neuropathic pain (Foot) 
T23 Female 12 CRPS (Foot) 
T24 Male 14 Abdominal pain, Nausea 
T25 Female 17 Abdominal/pelvic pain, Endometriosis 
T27 Female 17 Fibromyalgia, POTS, Headache, Abdominal pain 
T30 Female 13 CRPS (Right knee) 
T31 Female 15 POTS 
T32 Female 15 Neck pain 
Mean age was 13.7 ± 2.4 years. (CRPS: Complex regional pain syndrome; POS: Postural orthostatic 
tachycardia syndrome) 
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Table 2. Summary Data 
Patient # of Tx 
Sessions 
# of 
Total Tx 
Days 
# of Baseline 
Days 
% completed 
actigraph 
% 
completed 
DDs 
% Days 
analyzed 
T19 15 62 17 87 81 72 
T20 9 56 17 84 97 82 
T21 9 69 14 93 99 92 
T23 11 82 24 88 85 74 
T24 12 50 25 96 79 76 
T25 12 49 7 81 95 77 
T27 12 50 7 51 66 36 
T30 12 53 13 73 64 42 
T31 12 67 10 83 65 59 
T32 12 71 11 85 95 81 
Mean 11.6 60.9 14.5 81.9 82.7 69.1 
SD 1.7 11.1 6.3 12.7 13.9 17.9 
Range 9 - 15 49 - 82 7 - 25 73 - 96 64 -99 36 - 92 
(DD: daily diary; Tx: treatment) 
 
Daily Diary Measures  
 Summary statistics of daily fear, pain and avoidance scores over participants and 
days at each treatment phase are shown in Figure 4.  Avoidance scores were significantly 
lower at the Exposure phase compared to both Baseline and Education phases (p<0.05). 
Avoidance scores decreased over time for all but three participants (Figure 5). Fear 
(Figure 6) and pain (Figure 7) scores stayed approximately constant over time for most 
participants.  
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Figure 6. Daily Diary Measures. Y-axis values represent scores calculated from daily reports.  
Asterisks indicate significant differences (p<0.05) found by paired sample t-tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Average avoidance scores of each participant at each treatment phase. Mean avoidance 
scores across participants are shown in black (n=10).  
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Figure 8. Average fear scores of each participant at each treatment phase. Mean fear scores across 
participants are shown in black (n=10).  
 
 
 
Figure 9. Average pain scores of each participant at each treatment phase. Mean pain scores 
across participants are shown in black (n=10).  
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Actigraphy Measures 
 Physical activity levels were averaged over participants and days at each 
treatment phase. Both mean (Figure 6) and peak (Figure 7) activity levels remained at 
baseline levels throughout treatment. Physical activity levels were broken down by vigor 
into sedentary, light and moderate activity. Sedentary activity was defined as number of 
minutes per day with activity counts less than or equal to 40, light activity was defined as 
by activity counts between 40 and 1400, and moderate activity was defined by activity 
counts greater than or equal to 1400. Sedentary activity (Figure 8) levels at the Exposure 
phase were significantly greater than those at the Baseline and Education phases 
(p<0.05). Light (Figure 9) and moderate activity (Figure 10) levels remained constant 
throughout treatment.   
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Figure 10. Daily Mean Activity. Mean activity levels averaged over participants shown in black 
(n=10). 
 
 
Figure 11. Daily Peak Activity. Peak activity levels averaged over participants, shown in black 
(n=10). 
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Figure 12. Sedentary activity. Sedentary activity (number of minutes per day with activity 
counts less than or equal to 40) averaged over participants shown in black (n=10). The asterisk 
indicates significantly greater sedentary activity at the Exposure phase, compared to sedentary 
activity levels at both Baseline and Education phases (p<0.05) found by paired samples t-tests.  
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Figure 13. Light Activity. Light activity (number of minutes per day with activity counts between 
40 and 1400) averaged over participants shown in black (n=10). 
 
 
 
Figure 14. Moderate Activity. Moderate activity (number of minutes per day with activity counts 
greater than or equal to 1400) averaged over participants shown in black (n=10). 
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Multilevel Model of Physical Activity Change 
 A linear growth model for mean and peak activity was estimated in order to assess 
rate of change in physical activity levels. The complete study period including Baseline 
and Treatment phases was scaled from zero to one in order to make days across different 
participants comparable (Figure 11). Both mean and peak activity levels remained 
constant over time. Another linear model assessed time as either Baseline (0) or 
Treatment (1) (Figure 12). Both mean and peak activity levels remained constant 
between the two phases.   
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Figure 15. Time Course Models of (A) Mean and (B) Peak Activity. Each data point 
represents average physical activity (counts/min) of each day for each participant. The 
complete treatment period was scaled from 0-1 to make treatment days of different 
participants comparable.  	  
A	  
B	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Figure 16. Mean (A) and Peak (B) activity at baseline and treatment phases. The y-axis 
represents physical activity (counts/min). The x-axis indicates phase in which 0 represents 
Baseline and 1 represents Treatment.  	  
A	  
B	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Relationship between Daily Diary Measures and Physical Activity Levels 
 Pearson correlations were measured between daily diary and physical activity 
measures, averaged over days, at each treatment phase (Table 3). Higher avoidance 
scores were associated with lower peak activity levels across treatment phases. 
Avoidance scores were similarly inversely related to mean activity levels at baseline and 
education phases, but appeared unrelated at the exposure phase. Higher pain scores were 
associated with lower peak activity levels across treatment phases. Higher pain scores 
were also associated with lower mean activity levels at Baseline (r=-0.56; p<0.1) and 
Education phases (r=-0.54, p>0.1), with this relationship weakened in the exposure phase 
(r=-0.28; p>0.1). Higher fear scores were associated with higher mean and peak activity 
levels during the exposure phase, while they did not show correlations at baseline or 
education phases.  
 Pearson correlation coefficients were also calculated between daily diary 
measures and activity level types (Table 4). Higher avoidance scores were associated 
with more sedentary activity levels at the education phase. Higher fear scores were 
associated with less sedentary activity at the exposure phase and more light and moderate 
activity levels. However, they were not correlated with any activity level type at the 
baseline and education phases. Higher pain scores were associated with more light 
activity, primarily at the baseline and education phases, and less moderate activity at the 
education phase.  
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Table 3. Pearson Correlation Coefficients for Relationships between Daily Diary Scores and Mean and 
Peak Activity Levels 
    Baseline Education Exposure 
Mean 
PA 
Avoidance -0.32 -0.48 -0.21 
Fear -0.26 -0.13 0.38 
Pain -0.56 (0.091)* -0.54 (0.11) -0.28 
Peak 
PA 
Avoidance -0.33 -0.56 (0.091)* -0.34 
Fear -0.15 0.10 0.41 
Pain -0.66 (0.038)** -0.56 (0.095)* -0.44 
*p<0.1 
**p<0.05 
 
 
Table 4. Pearson Correlation Coefficients for Relationships between Daily Diary Scores and Sedentary, 
Light and Moderate Activity Levels  
Activity Level   Baseline Education Exposure 
Sedentary 
Avoidance 0.25 0.41 0.00 
Fear 0.03 -0.16 -0.58 (0.078)* 
Pain 0.36 0.20 0.01 
Light 
Avoidance 0.37 0.25 0.24 
Fear 0.39 0.26 0.46 
Pain 0.65 (0.042)** 0.58 (0.079)* 0.31 
Moderate 
Avoidance -0.10 -0.32 -0.02 
Fear -0.12 -0.14 0.44 
Pain -0.29 -0.46 -0.02 
*p<0.1 
**p<0.05 
 
Modeling Daily Diary Measures and Physical Activity Levels 
 Linear and quadratic regressions were used to more accurately model 
relationships between daily mean and peak activity levels and Avoidance (Figure 13) and 
Pain (Figure 14) scores (Table 5). Avoidance was better predictive of mean (R2=0.40, 
p=0.001) and peak activity (R2=0.36, p=0.002) using a quadratic model, rather than a 
linear model. Pain and both mean (R2=0.37, p=0.002) and peak activity (R2=0.33, 
p=0.004) also appeared to have moderate quadratic relationships.  
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Figure 17. Linear and quadratic regression models for avoidance and (A) mean 
and (B) peak physical activity. Y-axis indicates activity levels in counts/minute. 
Each data point represents average activity level of each treatment phase of each 
participant. 
A	  
B	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Figure 18. Linear and quadratic regression models for pain and (A) mean and (B) peak 
physical activity. Y-axis indicates activity levels in counts/minute. Each data point 
represents average activity level of each treatment phase of each participant. 
A	  
B	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Table 5. Regressions Modeling Daily Diary Measures and Physical Activity 
(PA: Physical activity) 
*p<0.1 
**p<0.05 
 
Linear mixed models were used to assess the effect of treatment phase on the 
relationships between daily diary measures and outcome physical activity levels (Table 
6). The avoidance score was a significant predictor of peak physical activity (p<0.05), 
independent of treatment phase. The pain score was also a significant predictor of both 
mean and peak physical activity (p<0.05) before and throughout treatment. 
 
  
IV DV Equation R Square F df1 df2 Sig. 
Avoidance 
Mean PA Linear 0.096 2.974* 1 28 0.096 Quadratic 0.399 8.958** 2 27 0.001 
Peak PA Linear 0.165 5.542** 1 28 0.026 Quadratic 0.36 7.61** 2 27 0.002 
Pain 
Mean PA Linear 0.195 6.7796** 1 28 0.014 Quadratic 0.369 7.882** 2 27 0.002 
Peak PA Linear 0.284 11.103** 1 28 0.002 Quadratic 0.333 6.737** 2 27 0.004 
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Table 6. Linear Mixed Models  
DV Source Numerator df 
Denominator 
df F Sig. 
Peak 
PA 
Avoidance 1 22.935 4.78** 0.039 
Phase 2 15.984 0.093 0.911 
Phase*Avoidance 2 14.703 0.159 0.855 
Fear 1 23.665 0.359 0.555 
Phase 2 16.984 0.603 0.558 
Phase*Fear 2 16.837 0.7 0.511 
Pain 1 23.455 10.547** 0.003 
Phase 2 15.509 0.205 0.817 
Phase*Pain 2 0.14 0.14 0.87 
Mean 
PA 
Avoidance 1 23.58 3.108 0.91 
Phase 2 18.822 0.595 0.562 
Phase*Avoidance 2 16.637 0.813 0.813 
Fear 1 22.177 0.035 0.853 
Phase 2 18.265 1.398 0.272 
Phase*Fear 2 18.264 1.018 0.381 
Pain 1 23.628 7.23** 0.013 
Phase 2 17.227 0.949 0.407 
Phase*Pain 2 16.979 0.535 0.595 
**p<0.05 
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DISCUSSION 	  
 
 The main goals of this study were to assess the effects of the GET Living 
treatment on physical activity and daily feelings of fear, pain and avoidance, as well as 
the relationships between these constructs. Online daily questionnaires and actigraphy 
were the methods used to evaluate treatment response. Results showed a significant 
decrease in average avoidance scores from baseline to both the Education and Exposure 
phases. Contrary to expectations, we did not observe an increase in physical activity with 
treatment. However, daily mean and peak physical activity levels remained at baseline 
levels throughout treatment and did not significantly decline. Sedentary activity increased 
significantly during the final phase of treatment, possibly due to patients spending more 
time in school. Interestingly, regression models presented a curvilinear relationship 
between avoidance and pain scores with physical activity. Moderate levels of avoidance 
and pain were associated with the lowest levels of physical activity, suggesting that this 
group is most in need of treatment that targets increased physical activity compared to 
patients with low levels or even high levels of avoidance. Moreover, linear mixed models 
showed that this curvilinear relationship was independent of treatment phase. We suspect 
this may be due to the daily diaries not being sensitive enough to daily changes; 
participants could have been answering questions with a general sense of their being in 
mind, rather than thinking only about that particular day. Additionally, the avoidance 
metric may not have been an accurate representation of the engagement or avoidance of 
physical activity. Avoidance scores were obtained from daily diaries by having patients 
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report ratings in response to the following statements: ‘I put things off because of my 
pain’ and ‘I avoided making plans because of my pain’. These statements do not address 
avoidance of physical activity specifically, and participants could have interpreted them 
to mean engaging in social or chore-like activities that may not necessarily involve 
physical activity. 
 Preliminary correlation analyses indicated negative correlations between pain 
scores and baseline activity levels. This result supports previous studies, which found 
pain perception to be inversely related to physical activity in adolescents with chronic 
pain (Long et al 2008, Rabbitts et al 2014, Wilson & Palermo 2012). These negative 
correlations were also found throughout treatment, though mean activity levels were not 
as related to pain scores during the Exposure phase. However, when activity was broken 
down by level of vigor, we found that moderate activity trended toward an inverse 
relationship with pain scores during Baseline and Education phases, but there was no 
apparent association during the Exposure phase. This suggests that the exposure 
treatment may have helped patients persist through physical activity regardless of 
perceived pain level. Regression analyses indicated that the physical activity and pain 
relationship better fit a curvilinear model. As expected, increased perceived pain was 
associated with decreased physical activity, but only up to a certain threshold; when the 
pain became more severe, physical activity was related with greater perceived pain. 
Linear mixed models showed this to be representative across all treatment phases. 
However, we expected treatment phase to have an effect on this relationship given the 
lack of association found at Exposure in the preliminary correlation analyses. Given our 
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small sample size, the data may not have been sensitive enough to a potential interaction 
between treatment phase and the physical activity and pain relationship. 
 Fear scores showed no correlations with activity levels at the Baseline and 
Education phases, but interestingly they increased with increasing light and moderate 
physical activity during the Exposure phase. Higher fear scores were also associated with 
decreased sedentary activity during Exposure. These results suggest that patients were 
engaging in physical activity despite feelings of fear during the Exposure treatment 
phase, while they may not have persisted through fearful feelings prior to Exposure. 
However, linear mixed models did not present any associations between fear and physical 
activity levels. This is likely due to low statistical power in the data, given the small 
sample size of ten subjects.  
 There are several limitations to be aware of in this study. As mentioned earlier, 
the sample size was small so statistical modeling may have been affected by low power. 
The subjectivity of daily diaries also gives rise to potential biases. We noted previously 
that the ambiguous wording of some of the questions could have led to misinterpretation. 
Additionally self-reports are susceptible to reporter bias; participants could have been 
exaggerating or suppressing feelings of fear or pain. Additionally, actigraphy measures 
are limited despite their objectivity. Physical functioning is multidimensional and 
actigraphy does not provide information about physical fitness or the purpose of physical 
activity (Wilson & Palermo 2012). Future studies should employ additional measures, 
like exercise tasks and physiological measures, in order to represent physical functioning 
more holistically (Arvidsson et al 2009, Eccleston et al 2003, Reid et al 2005). 
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Additionally, the present treatment study focuses on many values and goals, and with 
physical activity being only one, it may not be the most sensitive measure of treatment 
outcome.  
 There are also several external factors, such as paternal influence, sleep, 
medication use, mood, illness, and other life events, that have been shown to play a role 
in pain perception (Rabbitts et al 2014). These variables were not explicitly controlled for 
in the present study and thus may be potential confounds affecting the results. Previous 
findings have demonstrated the effects of protective parent responses on child treatment 
outcomes (Logan et al 2012, Simons et al 2011). It is important for future studies to 
measure parental distress when studying children with chronic pain, as parent 
encouragement or discouragement of their child avoiding activities would affect the 
child’s fear of pain and functional disability (Simons et al 2012a). Future studies should 
also take sleep quality into account as adolescents with comorbid pain and sleep 
disturbances have greater pain intensity and pain-related anxiety than those with just pain 
(Harrison et al 2016). Also youth with comorbid chronic pain and sleep problems are less 
active, more functionally impaired and exhibit more depressive symptoms (Palermo et al 
2008). Additionally, anxiety and mood disorders are frequently comorbid with chronic 
pain in youth (Vinall et al 2016). Simons et al (2012b) found that approximately one-
third of pediatric patients with persistent pain reported physiological anxiety. They also 
found that higher pain levels predicted higher levels of functional disability in children 
with low levels of worry; however functional disability could be high despite low pain 
levels in children with high levels of worry. Therefore anxiety, as well as other mental 
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health issues, should be considered when studying youth with chronic pain, given its high 
prevalence and significant role in mediating pain. Since many of these factors, including 
pain, physical activity, sleep and mood, are all inter-related, it would be insufficient to 
study just a few in isolation. Longitudinal studies should collect daily reports of these 
factors and take them into account when analyzing data. 
 Overall this study demonstrated the significant role of physical activity in 
avoidance and pain perception in youth with chronic pain. Including physical activity in 
future chronic pain treatments will be essential for addressing fear avoidance and 
improving physical functioning in this population. 
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